Aveo Pharmaceuticals Inc AVEO:NASDAQ

Last Price$4.15NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/18/22

Today's Change-0.10(2.35%)
Bid (Size)$2.60 (1)
Ask (Size)$4.17 (33)
Day Low / High$4.03 - 4.24
Volume171.5 K

Aveo Pharmaceuticals, Merck KgaA Enter Supply Deal for Head, Neck Cancer Trial

10:35AM ET 1/04/2022 MT Newswires
Aveo Pharmaceuticals (AVEO) said Tuesday it entered a clinical trial collaboration and supply agreement with Merck KgaA to evaluate ficlatuzumab in combination with Erbitux in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Under the collaborative deal, Merck KgaA will provide Erbitux, known generically as cetuximab, in all countries outside of the US and Canada for future registrational study, while Aveo will serve as the study sponsor and will shoulder the costs associated with conducting the trial, according to the statement.

Aveo said that it expects to begin manufacturing of ficlatuzumab clinical supply in Q2, subject to availability of key raw materials and manufacturing supplies, and to initiate a registrational study in the first half of 2023.

Price: 5.15, Change: -0.12, Percent Change: -2.26